VERACYTE INC (VCYT)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for VCYT
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| VCYT | «Board of Directors member, Fate Therapeutics, Inc. and Illumina, Inc.; Chair of the Board of Directors | 70 | ["Strategic consultant to life sciences companies since 2013","Former President of the Medco-UBC Division","Chief Research and Development Officer of Medco Health Solutions, Inc.","Chief Medical Officer of Medco from 1997 to 2010","Board member of Fate Therapeutics, Inc. since March 2014","Board member of Illumina, Inc. since November 2012","Former board member of Aveo Pharmaceuticals, Inc. from 2012 to 2014","Former Chairman of the Board of Decipher Biosciences, Inc. from 2019 to 2021","Former president of the International Society of Pharmacoeconomics and Outcomes Research","Served on the board of directors of the Drug Information Association","Served on the board of the International Society of Quality of Life","Experience with Centers for Disease Control and Prevention Committee","Experience with Agency for Healthcare Research and Quality Committee","Holds a B.S. in Biomedical Science","Holds an M.D. from the University of Michigan","Holds an M.S. in Preventive Medicine from the University of Maryland"] | ["Compensation","Nominating and Corporate Governance"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| FATE | Director | 70 | [] | [] | 2026 |
Biography sourced from the proxy statement filing.
Robert S. Epstein, M.D., M.S. , has served on our Board of Directors since January 2015 and is Chair of the Board of Directors. Dr. Epstein has served as a strategic consultant to life sciences companies since 2013. From 2010 to 2012, Dr. Epstein served as President of the Medco-UBC Division and as Chief Research and Development Officer of Medco Health Solutions, Inc., a managed healthcare company. Prior to that, Dr. Epstein served as Medco s Chief Medical Officer from 1997 to 2010. Dr. Epstein has served as a member of the board of directors of Fate Therapeutics, Inc. since March 2014 and Illumina, Inc. since November 2012. Dr. Epstein previously served as a member of the board of directors of Aveo Pharmaceuticals, Inc. from 2012 to 2014 and was Chairman of the Board of Decipher Biosciences, Inc. from 2019 until 2021. Dr. Epstein is the former president of the International Society of Pharmacoeconomics and Outcomes Research, and served on the board of directors of the Drug Information Association and the International Society of Quality of Life. He has also served on the Centers for Disease Control and Prevention Evaluation of Genomic Applications in Practice & Prevention Stakeholder Committee and the Agency for Healthcare Research and Quality Centers for Education and Research on Therapeutics Committee. Dr. Epstein holds a B.S. in Biomedical Science and an M.D. from the University of Michigan, and an M.S. in Preventive Medicine from the University of Maryland. We believe that Dr. Epstein is qualified to serve on our Board of Directors due to his extensive experience in strategic roles in healthcare companies, his expertise in reimbursement and FDA regulation, and his experience as a director of publicly traded companies in the life sciences industry. Age: 70 Director Since: 2015 Committees: Nominating and Corporate Governance (Chair)